Andreas Naegeli

Andreas Nägeli is Head of Business Development at Genovis, where he works at the interface between the scientific and commercial organizations to support the adoption of SmartEnzyme technologies in biopharmaceutical research and development. Since joining Genovis in 2018, he has held several roles in Applications and R&D before transitioning into business development in 2023. During this time, he contributed to the development of new SmartEnzyme products and analytical workflows that are now widely used for the characterization and modification of biotherapeutics. Andreas holds a PhD in Microbiology from ETH Zurich, where he studied bacterial glycosylation systems and their biotechnological applications.